Anaplastic Ependymoma and Atypical Refractory Longitudinal Expansive Transverse Myelitis Due to Immune Reaction After COVID-19-A Case Discussion That Raises Many Unknown Questions About Covid-19 COVID-19 Sonrası İmmün Reaksiyona Bağlı Atipik Refrakter Longitudinal Ekspansif Transvers Miyelit ve Anaplastik Ependimom - COVID-19 Hakkında Birçok Bilinmeyen Soruyu Gündeme Getiren Bir Vaka Tartışması

İNALKAÇ GEMİCİ Y., ÇELİK F., GÖZ Z. Z., İşisağ A., YILMAZ OVALI G., Zileli M., ...Daha Fazla

Noropsikiyatri Arsivi, cilt.61, sa.4, ss.374-376, 2024 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 61 Sayı: 4
  • Basım Tarihi: 2024
  • Doi Numarası: 10.29399/npa.28464
  • Dergi Adı: Noropsikiyatri Arsivi
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, Psycinfo, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.374-376
  • Anahtar Kelimeler: Anaplastic ependymoma, COVID-19, Longitudinal extensive transvers myelitis
  • Manisa Celal Bayar Üniversitesi Adresli: Evet

Özet

Inflammatory neurologic manifestations, both infectious and non-infectious, have been reported secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19). However, the relationship of spinal tumor and COVID-19 longitudinally extensive transverse myelitis (LETM) coexistence has never been reported in our knowledge. The clinical presentation and response to treatment of a 24-year-old female patient diagnosed with COVID-19 LETM and anaplastic ependymoma are described in this case report. The Patient’s cerebrospinal fluid COVID-19 antibody level was higher than serum and she was resistant to immunosuppressive treatment. The interaction between COVID-19 and spinal tumor was discussed in the light of the literature. It is thought that COVID-19 infection could trigger tumor growth in this patient. Also, this is the first case of anaplastic ependymoma and COVID-19 myelitis coexistence in the literature.